Marshall Wace Portfolio holdings
AUM
$84.1B
1-Year Return
27.54%
This Quarter Return
+7.19%
1 Year Return
+27.54%
3 Year Return
+105.03%
5 Year Return
+179.94%
10 Year Return
+445.45%
AUM
$19B
AUM Growth
+$3.18B
(+20%)
Cap. Flow
+$2.4B
Cap. Flow
% of AUM
12.63%
Top 10 Holdings %
Top 10 Hldgs %
13.58%
Holding
2,946
New
1,034
Increased
512
Reduced
491
Closed
671
Top Buys
| 1 |
PARA
Paramount Global Class B
PARA
|
+$268M |
| 2 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
+$158M |
| 3 |
Tencent Music
TME
|
+$149M |
| 4 |
Baidu
BIDU
|
+$122M |
| 5 |
Bio-Rad Laboratories Class A
BIO
|
+$114M |
Top Sells
| 1 |
Carnival Corp
CCL
|
+$213M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$195M |
| 3 |
Zoetis
ZTS
|
+$181M |
| 4 |
Guardant Health
GH
|
+$137M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$127M |
Sector Composition
| 1 | Healthcare | 23% |
| 2 | Consumer Discretionary | 15.1% |
| 3 | Technology | 12.3% |
| 4 | Financials | 11.26% |
| 5 | Communication Services | 9.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1626
CVR Energy
CVI
$3.13B
| $518K | ﹤0.01% |
+27,041
| New | +$518K |
|
1627
iShares MSCI EAFE ETF
EFA
$67.1B
| $517K | ﹤0.01% |
+6,816
| New | +$517K |
|
1628
Tiziana Life Sciences
TLSA
$197M
| $517K | ﹤0.01% |
+186,471
| New | +$517K |
|
1629
C3.ai
AI
$2.26B
| $516K | ﹤0.01% |
7,834
-1,860
| -19% | -$123K |
|
1630
Cintas
CTAS
$81.6B
| $516K | ﹤0.01% |
6,048
-70,820
| -92% | -$6.04M |
|
1631
Harmony Biosciences
HRMY
$1.86B
| $514K | ﹤0.01% |
+15,545
| New | +$514K |
|
|
BPFH
1632
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
| $514K | ﹤0.01% |
+38,624
| New | +$514K |
|
1633
New Oriental
EDU
$8.79B
| $513K | ﹤0.01% |
3,665
-62,427
| -94% | -$8.74M |
|
1634
Hamilton Beach Brands
HBB
$196M
| $508K | ﹤0.01% |
28,032
+16,565
| +144% | +$300K |
|
1635
Oshkosh
OSK
$8.77B
| $507K | ﹤0.01% |
4,272
+1,688
| +65% | +$200K |
|
1636
Coherus Oncology, Inc. Common Stock
CHRS
$150M
| $505K | ﹤0.01% |
+34,610
| New | +$505K |
|
1637
Symbotic
SYM
$5.32B
| $505K | ﹤0.01% |
+50,000
| New | +$505K |
|
1638
Agnico Eagle Mines
AEM
$77B
| $503K | ﹤0.01% |
8,700
+2,931
| +51% | +$169K |
|
1639
MACOM Technology Solutions
MTSI
$9.82B
| $503K | ﹤0.01% |
8,678
+975
| +13% | +$56.5K |
|
1640
Northwest Natural Holdings
NWN
$1.73B
| $501K | ﹤0.01% |
9,294
-4,422
| -32% | -$238K |
|
1641
Coterra Energy
CTRA
$18.6B
| $500K | ﹤0.01% |
+26,609
| New | +$500K |
|
1642
Tantech Holdings
TANH
$2.78M
| $500K | ﹤0.01% |
+36
| New | +$500K |
|
1643
Digi International
DGII
$1.33B
| $499K | ﹤0.01% |
+26,287
| New | +$499K |
|
1644
vTv Therapeutics
VTVT
$51.7M
| $499K | ﹤0.01% |
+4,425
| New | +$499K |
|
1645
Select Water Solutions
WTTR
$946M
| $497K | ﹤0.01% |
+99,893
| New | +$497K |
|
1646
NextCure
NXTC
$14.5M
| $496K | ﹤0.01% |
4,130
-431
| -9% | -$51.8K |
|
|
SRT
1647
DELISTED
Startek Inc.
SRT
| $495K | ﹤0.01% |
+62,322
| New | +$495K |
|
1648
Humacyte
HUMA
$233M
| $494K | ﹤0.01% |
+45,590
| New | +$494K |
|
|
TCRR
1649
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $491K | ﹤0.01% |
22,211
+1,707
| +8% | +$37.7K |
|
|
EFTR
1650
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
| $486K | ﹤0.01% |
+1,999
| New | +$486K |
|